AdvisorShares Investments LLC lessened its holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 18.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,362 shares of the biopharmaceutical company’s stock after selling 3,053 shares during the period. AdvisorShares Investments LLC’s holdings in […]

Related Keywords

China , Zurcher Kantonalbank Zurich Cantonalbank , Advisorshares Investments , China Universal Asset Management Co , Securities Exchange Commission , Sage Therapeutics Inc , Quest Partners , Morgan Stanley , Nasdaq , Sage Therapeutics , Free Report , Shares Investments , Universal Asset Management , Kantonalbank Zurich Cantonalbank , Get Free Report , Truist Financial , Sage Therapeutics Daily ,